DK0593450T3 - Præparater omfattende omega-conotoxin-peptidderivater og deres anvendelse til behandling af neuronal beskadigelse med relation til iskæmi - Google Patents

Præparater omfattende omega-conotoxin-peptidderivater og deres anvendelse til behandling af neuronal beskadigelse med relation til iskæmi

Info

Publication number
DK0593450T3
DK0593450T3 DK91901056.1T DK91901056T DK0593450T3 DK 0593450 T3 DK0593450 T3 DK 0593450T3 DK 91901056 T DK91901056 T DK 91901056T DK 0593450 T3 DK0593450 T3 DK 0593450T3
Authority
DK
Denmark
Prior art keywords
omega
ischemia
compositions
treatment
neuronal damage
Prior art date
Application number
DK91901056.1T
Other languages
English (en)
Inventor
Stephen S Bowersox
George P Miljanich
Robert S Bitner
James A Fox
Karen L Valentino
Donald H Yamashiro
Original Assignee
Neurex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurex Corp filed Critical Neurex Corp
Application granted granted Critical
Publication of DK0593450T3 publication Critical patent/DK0593450T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DK91901056.1T 1989-11-22 1990-11-21 Præparater omfattende omega-conotoxin-peptidderivater og deres anvendelse til behandling af neuronal beskadigelse med relation til iskæmi DK0593450T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/440,094 US5051403A (en) 1989-11-22 1989-11-22 Method of treating ischemia-related neuronal damage

Publications (1)

Publication Number Publication Date
DK0593450T3 true DK0593450T3 (da) 1996-11-25

Family

ID=23747411

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91901056.1T DK0593450T3 (da) 1989-11-22 1990-11-21 Præparater omfattende omega-conotoxin-peptidderivater og deres anvendelse til behandling af neuronal beskadigelse med relation til iskæmi

Country Status (11)

Country Link
US (1) US5051403A (da)
EP (1) EP0593450B1 (da)
JP (1) JP3809184B2 (da)
AT (1) ATE140388T1 (da)
AU (1) AU648052B2 (da)
CA (1) CA2045473C (da)
DE (1) DE69027865T2 (da)
DK (1) DK0593450T3 (da)
ES (1) ES2091906T3 (da)
GR (1) GR3021087T3 (da)
WO (1) WO1991007980A1 (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5386025A (en) * 1990-02-20 1995-01-31 The Salk Institute Biotechnology/Industrial Associates Calcium channel compositions and methods
US5407820A (en) * 1988-04-04 1995-04-18 The Salk Institute Biotechnology/Industrial Associates, Inc. Calcium channel α-2 subunit DNAs and cells expressing them
US6653097B1 (en) 1991-08-15 2003-11-25 Merck & Co., Inc. Human calcium channel compositions and methods
US6387696B1 (en) 1988-04-04 2002-05-14 Merck & Co., Inc. Human calcium channel compositions and methods
US6096514A (en) * 1988-04-04 2000-08-01 Sibia Neurosciences, Inc. Human calcium channel compositions and methods
US5874236A (en) * 1988-04-04 1999-02-23 Sibia Neurosciences. Inc. DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits
US5846757A (en) * 1988-04-04 1998-12-08 Sibia Neurosciences, Inc. Human calcium channel α1, α2, and β subunits and assays using them
US20040018510A1 (en) 1990-11-08 2004-01-29 Merck & Co., Inc. Human calcium channel compositions and methods
US5876958A (en) * 1988-04-04 1999-03-02 Sibia Neurosciences, Inc. Assays of cells expressing human calcium channels containing α1 β subunits
US5851824A (en) * 1988-04-04 1998-12-22 Sibia Neurosciences, Inc. Human calcium channel α-1C/α-1D, α-2, β-1, and γsubunits and cells expressing the DNA
ATE139542T1 (de) 1988-04-04 1996-07-15 Salk Inst Biotech Ind Calciumkanal-zusammensetzungen und verfahren
US5264371A (en) * 1989-11-22 1993-11-23 Neurex Corporation Screening method for neuroprotective compounds
US5559095A (en) * 1989-11-22 1996-09-24 Neurex Corporation Delayed treatment method of reducing ischemia-related neuronal damage
WO1993010145A1 (en) * 1991-11-12 1993-05-27 Neurex Corporation Compositions for delayed treatment of ischemia-related neuronal damage
SG50624A1 (en) * 1991-12-30 1998-07-20 Neurex Corp Methods of producing analgesia and enhancing opiate analgesia
EP0556160A3 (en) * 1992-02-11 1993-10-27 Sandoz Ag Insecticidal toxins from plectreurys tristis
JPH07505908A (ja) * 1992-09-28 1995-06-29 マックセチーニ、マリア　ルイザ Ｎｍｄａ受容体のアロステリックモジュレーター
US5854217A (en) * 1992-09-28 1998-12-29 Bearsden Bio, Inc. Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
US5514774A (en) * 1993-06-29 1996-05-07 University Of Utah Research Foundation Conotoxin peptides
US5591821A (en) * 1993-07-16 1997-01-07 The University Of Utah Omega-conotoxin peptides
US6090623A (en) * 1993-08-11 2000-07-18 Merck & Co., Inc. Recombinant human calcium channel β4 subunits
US5739276A (en) * 1994-10-07 1998-04-14 University Of Utah Research Foundation Conotoxin peptides
US5670622A (en) * 1996-02-15 1997-09-23 University Of Utah Research Foundation Conotoxin peptide PIIIA
US6054429A (en) * 1996-03-08 2000-04-25 Elan Pharmaceuticals, Inc. Epidural method of producing analgesia
DE69627153T2 (de) * 1995-06-27 2003-12-04 Elan Pharmaceuticals, Inc.(N.D.Ges.D.Staates Delaware) Zusammensetzungen zur erzielung von analgesie und zur hemmung der progression neuropathischer schmerzerkrankungen
US5965534A (en) * 1995-11-22 1999-10-12 Alcon Laboratories, Inc. Use of ω-conotoxin analogs for treating retinal and optic nerve head damage
US5672682A (en) * 1996-03-18 1997-09-30 University Of Utah Research Foundation Conotoxin peptide PVIIA
US6528630B1 (en) 1997-12-03 2003-03-04 Merck & Co., Inc. Calcium channel compositions and methods
US6379882B1 (en) 1998-09-14 2002-04-30 Elan Pharmaceuticals, Inc. Method for selecting compounds for treating ischemia-related cellular damage
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
WO2000020018A1 (en) * 1998-10-06 2000-04-13 Cognetix, Inc. Kappa-a conopeptides and uses therefor
WO2000021550A2 (en) * 1998-10-13 2000-04-20 President And Fellows Of Harvard College Methods and compositions for treating neurodegenerative diseases
US6855805B2 (en) 1999-01-22 2005-02-15 University Of Utah Research Foundation α-conotoxin peptides
WO2000043409A2 (en) 1999-01-22 2000-07-27 University Of Utah Research Foundation Alpha-conotoxin peptides
AU783925B2 (en) * 1999-08-10 2005-12-22 Uab Research Foundation Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins
CA2396529A1 (en) 1999-12-30 2001-07-12 University Of Utah Research Foundation O-superfamily conotoxin peptides
EP2412719A1 (en) 2002-12-02 2012-02-01 Xenome Ltd Chi-conotoxin peptides
WO2004050690A1 (en) 2002-12-02 2004-06-17 Xenome Ltd NOVEL χ-CONOTOXIN PEPTIDES (-I)
US20060019892A1 (en) * 2003-03-05 2006-01-26 Florida Atlantic University Conopeptides and methods of use
US20090062211A1 (en) * 2003-03-05 2009-03-05 Florida Atlantic University Conopeptides and methods of use
US7268109B2 (en) 2003-10-02 2007-09-11 Elan Pharmaceuticals, Inc. Method for reducing pain
ATE471147T1 (de) * 2004-09-10 2010-07-15 Newron Pharm Spa Verwendung von (r)-(halogenbenzyloxy)-benzylamino-propanamiden als natrium- und/oder calciumkanal- selektive modulatoren
CN1304422C (zh) * 2005-09-15 2007-03-14 浙江大学 非酰胺化ω－芋螺毒素M ⅦA 及其制备方法和应用
EP1963280B1 (en) * 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
PT2155663T (pt) 2007-06-15 2018-01-16 Newron Pharm Spa Derivados de 2-[2-(fenil)etilamino]alcanamida substituídos e sua utilização como moduladores dos canais de sódio e/ou de cálcio
US8765677B2 (en) 2009-09-21 2014-07-01 The University Of Queensland Omega conotoxin peptides
ES2602140T3 (es) 2011-06-27 2017-02-17 Newron Pharmaceuticals S.P.A. Derivados de arilalquilaminocarboxamida fluorados
WO2016191200A1 (en) 2015-05-22 2016-12-01 Clemson University Conotoxin peptides for use in biofouling deterrence

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447356A (en) * 1981-04-17 1984-05-08 Olivera Baldomero M Conotoxins
US4925664A (en) * 1986-10-20 1990-05-15 University Of Utah Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function
US4950739A (en) * 1988-02-10 1990-08-21 New York University Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels

Also Published As

Publication number Publication date
DE69027865T2 (de) 1997-01-02
EP0593450A1 (en) 1994-04-27
DE69027865D1 (de) 1996-08-22
AU648052B2 (en) 1994-04-14
ES2091906T3 (es) 1996-11-16
US5051403A (en) 1991-09-24
CA2045473C (en) 2002-09-17
GR3021087T3 (en) 1996-12-31
JP3809184B2 (ja) 2006-08-16
ATE140388T1 (de) 1996-08-15
WO1991007980A1 (en) 1991-06-13
JPH05501715A (ja) 1993-04-02
HK1006810A1 (en) 1999-03-19
CA2045473A1 (en) 1991-05-23
EP0593450B1 (en) 1996-07-17
AU6964091A (en) 1991-06-26

Similar Documents

Publication Publication Date Title
DK0593450T3 (da) Præparater omfattende omega-conotoxin-peptidderivater og deres anvendelse til behandling af neuronal beskadigelse med relation til iskæmi
DK371389A (da) Substituerede aminomethyltetraliner og deres heterocycliske analoge, deres fremstilling og anvendelse
NO922275D0 (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
NO175204C (no) Imidoperoksikarboksylsyrer, fremgangsmåte for deres fremstilling og anvendelse
DK518187A (da) Fremgangsmaade og farmaceutisk praeparat til stimulering af melaminproduktionen i et pattedyr
DK442788A (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
DK0527879T3 (da) Synergistiske terapeutiske præparater og fremgangsmåder.
DK273689D0 (da) 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
DK660788D0 (da) 2,2-difluorcyklopropylethanderivater, fremgangsmaade til deres fremstilling og deres anvendelse som skadedyrsbekaempelsesmiddel
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
DK275487D0 (da) 1,2,3,6-tetrahydro-5-nitro-pyrimidinderivater, fremgangsmaade til deres fremstilling og deres anvendelse til bekaempelse af skadelige organismer
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
DK568287D0 (da) Relativt lavmolekylaere peptider og deres anvendelse som renininhibitorer
DK1009750T3 (da) Nye (alfa-aminophosphino)peptid derivater, fremgangsmåde til deres fremstilling og deres terapeutiske anvendelse
DK19887D0 (da) Peptider med vasorelaxerende, natriuretisk og diuretisk virkning, fremgangsmaade til deres fremstiling, midler indeholdende forbindelserne og deres anvendelse
DK667489A (da) Ikke-asbestholdig, uorganisk haerdet sammensaetning og fremgangsmaade til fremstilling heraf
NO951418D0 (no) Peptidderivater, deres fremstilling og anvendelse som terapeutika
DK530689A (da) Adenylcyclasederivater, fremgangsmaade til fremstilling deraf og deres anvendelse
NO881778D0 (no) Inkastiner: nye glykopeptider med enkefalinase-hemmende virkning. fremgangsmaate til deres fremstilling og deres anvendelse som farmasoeytiske preparater.
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
DK578789A (da) Pyrrolidin-2-carboxylsyre-derivater med psykotrop virkning, deres fremstilling og anvendelse
DK698188D0 (da) Peptider, deres fremstilling og anvendelse
DK421389D0 (da) Aminomethyl-peptider, deres fremstilling og anvendelse som laegemidler
NO992436D0 (no) N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse
DK220389D0 (da) Synergistiske kombinationspraeparater og deres anvendelse som terapeutika